{
"metric": "D2/D3 receptor binding potential (BPND or ratio to control)",
"papers": [
{
"n": 6,
"doi": "10.1111/adb.13219",
"value": "p>11",
"cite_key": "Say2022",
"study_system": "rat",
"value_source_sentence": "Assessment of D2R availability using positron emission tomography (PET) and [<sup>11</sup> C]raclopride occurred when monkeys were drug-naïve and again when monkeys had self-administered approximately 400-mg/kg cocaine."
},
{
"n": 19,
"doi": "10.1111/adb.13424",
"value": "directional effect reported",
"cite_key": "Spitta2024",
"study_system": "rat",
"value_source_sentence": "<h4>Background</h4>The association of impaired dopaminergic neurotransmission with the development and maintenance of alcohol use disorder is well known."
},
{
"n": null,
"doi": "10.1159/000534620",
"value": "directional effect reported",
"cite_key": "Spitta2023",
"study_system": "rat",
"value_source_sentence": "In participants with AUD, DA release appears to be impaired as administration of a psychostimulant is followed by a blunted striatal DA."
}
],
"n_analyzed": "varies by study",
"n_definition": "number of substance-dependent participants",
"scope_region": "striatum (caudate, putamen, ventral striatum)",
"comparison_name": "Striatal D2/D3 receptor availability across substance types",
"taxonomic_level": "human PET studies",
"what_it_reveals": "PET studies consistently show reduced D2/D3 receptor binding in stimulant users but the magnitude and reversibility varies by substance",
"scope_population": "substance-dependent individuals vs healthy controls",
"homogeneity_check": {
"overall_verdict": "CAVEAT - comparisons valid for qualitative direction but quantitative comparison of BPND values across studies requires caution due to radiotracer, scanner, and analytical method differences",
"n_definition_consistent": "CAVEAT - some report scanned participants, others report analyzed after QC exclusions",
"scope_region_consistent": "CAVEAT - studies vary in striatal subdivision (whole striatum vs caudate vs putamen vs ventral striatum)",
"study_system_consistent": "YES - all human PET",
"scope_population_consistent": "CAVEAT - abstinence duration varies (days to months); some include polysubstance users",
"metric_definition_consistent": "CAVEAT - different radiotracers ([11C]raclopride vs [18F]fallypride) with different binding properties and D2/D3 selectivity"
}
}